Home
Resources
Follow portfolio news
...

ScreenPoint and Ikonopedia join forces to prevent breast cancer

Published on
16/7/2025
Amended on
25/3/2026
0
minute(s)
Odyssey 2021
ScreenPoint
Featured in theOdyssey FPCI Altaroc Odyssey Vintage , ScreenPoint has already analyzed more than 5 million mammograms in 30 countries. Thanks to its artificial intelligence, trained on over a million images, the Dutch company enables faster and more accurate diagnoses. Ikonopedia is integrating its AI solution to improve breast cancer detection in the United States.
By
Antoine Orsoni
Antoine Orsoni
ScreenPoint and Ikonopedia join forces to prevent breast cancer
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
This article has been automatically translated. We apologize per inaccuracies or translation errors.

Ikonopedia has partnered with ScreenPoint Medical to integrate Transpara Breast, ScreenPoint's breast cancer detection AI, directly into its workspace. This alliance underlines the importance of Transpara, which combines clinical rigor with agility in operational practice. Ikonopedia's medical network - which includes prestigious centers on American soil such as Mount Sinai Staten Island, the Marshfield Clinic, with 8 imaging centers and 3 mobile units, and Skagit Radiology - can now rely on this AI. It has been trained on a vast dataset comprising one million images and 15,000 cancer cases from various mammography models and medical centers. The algorithm's results are not merely theoretical, as they are verified by biopsies. To date, this artificial intelligence has analyzed over 5 million mammograms in more than 30 countries, in collaboration with radiologists, for ever more accurate diagnoses.

"While AI is attracting considerable attention, it is delivering truly measurable value in healthcare," confides Emily Crane, CEO of Ikonopedia. The latter is transforming the way radiologists track and interpret examinations. The intuitive cloud platform documents every step of the patient journey, from appointment booking to post-examination follow-up, ensuring full traceability of any anomalies detected. Designed by radiologists, for radiologists, Ikonopedia's solution replaces fixed, manual medical reports with intelligent, interactive reports that comply with the most stringent American standards. Artificial intelligence is playing an increasingly important role in this field, offering cutting-edge analysis and diagnosis. This partnership is no exception, providing healthcare professionals with acute analysis of mammography images.

Around 2 million women worldwide are diagnosed with breast cancer every year. By promoting early detection of breast cancer, thanks to players like ScreenPoint, it's easier for healthcare professionals to provide the right treatment, as early as possible.

Other episodes on this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
No articles in this category yet.
No items found.
North America
Healthcare
Welcome to Altaroc
To provide you with a tailored experience, please complete your profile.
Your profile
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
YOUR INVESTOR PROFILE
Financial intermediary or professional investor
Financial advisors, wealth managers, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced investor or Altaroc investor
Private investors who have already invested with Altaroc or who have a minimum investment capacity of €100,000.
Private investors who have previously invested in Altaroc who have a minimum investment capacity of 200,000 euros.
Non-professional (retail) investor
Individual investors with an investment capacity below €100,000.
Retail investors with an investment capacity of less than 200,000 euros.
Institutional investor
Pension funds, retirement schemes, asset management companies, and single-family offices.
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.